HSD3B1 and breast carcinoma: Our findings showed that LRH1 inhibition significantly decreases HSD3B1 expression, while LRH1 overexpression increases it, supporting a conserved regulatory mechanism across multiple breast cancer models (Fig. S2, B and C).